First human test for potential kidney disease treatment begins
NCT ID NCT07024823
Summary
This is the first study in people to test the safety of an experimental drug called AZD4248. Researchers will give single and multiple doses to healthy volunteers and people with diabetic kidney disease to see how the body handles it and check for side effects. A separate part of the study will also test if people can reliably measure their own kidney function from home using a special device.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGGlendale, California, 91206, United States
-
Research Site
RECRUITINGChicago, Illinois, 60643, United States
-
Research Site
RECRUITINGAnn Arbor, Michigan, 48109, United States
-
Research Site
RECRUITINGSaint Paul, Minnesota, 55114, United States
-
Research Site
RECRUITINGSan Antonio, Texas, 78215, United States
Conditions
Explore the condition pages connected to this study.